Free samples available with shipping and taxes paid by the buyer
Packaging Details
Blister, 20*10
Main Export Market(s)
Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia
Main Domestic Market
All India
Certifications
WHO-GMP
Betahistine Mesylate 8 Mg About
Meta-analysis supports the therapeutic benefit of betahistine on vertiginous symptoms in Menieres disease & vestibular vertigo. Betahistine is more effective than placebo or flunarizine in menieres desease and related conditions. Comparative studies of betahistine with the fixed combination of cinnarizine and dimenhydrinate are equivocal. Dosage: Initially two tablets three daily to be taken prefferably with meals
FAQs of Betahistine Mesylate 8 Mg:
Q: What is the primary function of Betahistine Mesylate 8 Mg tablets?
A: Betahistine Mesylate 8 Mg tablets are primarily designed to treat gastric issues.
Q: Who is Betahistine Mesylate 8 Mg recommended for?
A: It is recommended for individuals experiencing vomiting caused by specific underlying conditions.
Q: What is the active ingredient in this product?
A: The active ingredient is Betahistine Mesylate.
Q: What is the physical form of Betahistine Mesylate 8 Mg?
A: The product is available in tablet form.
Q: What type of drug is Betahistine Mesylate 8 Mg?
A: It is classified as a specific drug designed for targeted therapeutic applications.
Tell us about your requirement
Price:
Quantity
Select Unit
50
100
200
250
500
1000+
Additional detail
Mobile number
Email
Name
Comapny Name
Phone Number
Email Id
City / State
Confirm Your Requirement
Verification Code
Did not receive yet?
Resend OTP
You’re Done!
We have received your requirements and will reply shortly with the best price.